Rankings
▼
Calendar
LXRX Q3 2016 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$729M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$28M
Gross Profit
-$25M
-89.5% margin
Operating Income
-$35M
-126.0% margin
Net Income
-$36M
-129.9% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+38.0%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$517M
Total Liabilities
$332M
Stockholders' Equity
$185M
Cash & Equivalents
$396M
← FY 2016
All Quarters
Q4 2016 →
